Potentiation of amyloid-β peptide neurotoxicity in human dental-pulp neuron-like cells by the membrane lipid peroxidation product 4-hydroxynonenal

Free Radical Biology and Medicine

Volumn 53, Issue 9, 2012, Pages 1708-1717

  Testa, Gabriella ^a   Gamba, Paola ^a   Di Scipio, Federica ^a   Sprio, Andrea Elio ^a   Salamone, Paolina ^a   Gargiulo, Simona ^a   Sottero, Barbara ^a   Biasi, Fiorella ^a   Berta, Giovanni Nicolao ^a   Poli, Giuseppe ^a   Leonarduzzi, Gabriella ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

4 Hydroxynonenal; Amyloid ; CD36 scavenger receptor; Cell death

Indexed keywords

4 HYDROXYNONENAL; AMYLOID BETA PROTEIN[1-42]; BETA1 INTEGRIN; CD36 ANTIGEN; CD47 ANTIGEN; COMPLEMENTARY DNA; MESSENGER RNA; SCAVENGER RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL DEATH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; NERVE CELL; NEUROTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOOTH PULP;

ADULT; ALDEHYDES; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIGENS, CD29; ANTIGENS, CD36; ANTIGENS, CD47; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL DIFFERENTIATION; CELL NUCLEUS SHAPE; CELL SHAPE; CELLS, CULTURED; DENTAL PULP; FEMALE; GENE EXPRESSION; HUMANS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MEMBRANE LIPIDS; NECROSIS; NEURONS; PRIMARY CELL CULTURE; STEM CELLS; UP-REGULATION;

EID: 84866706393     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.08.581     Document Type: Article

References (65)

1. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N. Engl. J. Med. 362 2010 329 344
2. K. Chopra, S. Misra, and A. Kuhad Neurobiological aspects of Alzheimer's disease Expert Opin. Ther. Targets 15 2011 535 555
3. M.N. Rossor, N.C. Fox, P.A. Freeborough, and R.J. Harvey Clinical features of sporadic and familial Alzheimer's disease Neurodegeneration 5 1996 393 397
4. R.E. Tanzi, and L. Bertram New frontiers in Alzheimer's disease genetics Neuron 32 2001 181 184
5. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N. Engl. J. Med. 362 2010 329 344
6. C. Jeandel, M.B. Nicolas, F. Dubois, F. Nabet-Belleville, F. Penin, and G. Cuny Lipid peroxidation and free radical scavengers in Alzheimer's disease Gerontology 35 1989 275 282
7. Z. Zaman, S. Roche, P. Fielden, P.G. Frost, D.C. Niriella, and A.C. Cayley Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease Age Ageing 21 1992 91 94
8. M. Arca, S. Natoli, F. Micheletta, S. Riggi, E. Di Angelantonio, A. Montali, T.M. Antonini, R. Antonini, U. Diczfalusy, and L. Iuliano Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy Free Radic. Biol. Med. 42 2007 698 705
9. E.K. Long, and M.J. Picklo Sr. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE Free Radic. Biol. Med. 49 2010 1 8
10. P.H. Axelsen, H. Komatsu, and I.V. Murray Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease Physiology (Bethesda) 26 2011 54 69
11. I.V. Murray, J.F. Proza, F. Sohrabji, and J.M. Lawler Vascular and metabolic dysfunction in Alzheimer's disease: a review Exp. Biol. Med. (Maywood) 236 2011 772 782
12. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen, and M.A. Smith Oxidative damage is the earliest event in Alzheimer disease J. Neuropathol. Exp. Neurol. 60 2001 759 767
13. X. Zhu, B. Su, X. Wang, M.A. Smith, and G. Perry Causes of oxidative stress in Alzheimer disease Cell. Mol. Life Sci. 64 2007 2202 2210
14. M.A. Smith, X. Zhu, M. Tabaton, G. Liu, D.W. McKeel Jr, M.L. Cohen, X. Wang, S.L. Siedlak, B.E. Dwyer, T. Hayashi, M. Nakamura, A. Nunomura, and G. Perry Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment J. Alzheimers Dis. 19 2010 363 372
15. D.J. Bonda, X. Wang, G. Perry, A. Nunomura, M. Tabaton, X. Zhu, and M.A. Smith Oxidative stress in Alzheimer disease: a possibility for prevention Neuropharmacology 59 2010 290 294
16. R. Naylor, A.F. Hill, and K.J. Barnham Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible? Eur. Biophys. J. 37 2008 265 268
17. D. Paola, C. Domenicotti, M. Nitti, A. Vitali, R. Borghi, D. Cottalasso, D. Zaccheo, P. Odetti, P. Strocchi, U.M. Marinari, M. Tabaton, and M.A. Pronzato Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells Biochem. Biophys. Res. Commun. 268 2000 642 646
18. D. Praticò, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4183 4187
19. T. Harkany, I. Abrahám, C. Kónya, C. Nyakas, M. Zarándi, B. Penke, and P.G. Luiten Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy Rev. Neurosci. 11 2000 329 382
20. Q. Ding, E. Dimayuga, and J.N. Keller Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease Curr. Alzheimer Res. 4 2007 73 79
21. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
22. M.P. Mattson Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders Exp. Gerontol 44 2009 625 633
23. D.S. Wang, N. Iwata, E. Hama, T.C. Saido, and D.W. Dickson Oxidized neprilysin in aging and Alzheimer's disease brains Biochem. Biophys. Res. Commun. 310 2003 236 241
24. T.I. Williams, B.C. Lynn, W.R. Markesbery, and M.A. Lovell Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease Neurobiol. Aging 27 2006 1094 1099
25. D.A. Butterfield, V. Galvan, M.B. Lange, H. Tang, R.A. Sowell, P. Spilman, J. Fombonne, O. Gorostiza, and J. Zhang Sultana, R.; Bredesen, D. E. In vivo oxidative stress in brain of Alzheimer disease transgenic mice: requirement for methionine 35 in amyloid beta-peptide of APP Free Radic. Biol. Med. 48 2010 136 144
26. E. Tamagno, M. Parola, P. Bardini, A. Piccini, R. Borghi, M. Guglielmotto, G. Santoro, A. Davit, O. Danni, M.A. Smith, G. Perry, M. Tabaton, and A.P.P. Beta-site cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways J. Neurochem. 92 2005 628 936
27. D.G. Jo, T.V. Arumugam, H.N. Woo, J.S. Park, S.C. Tang, M. Mughal, D.H. Hyun, J.H. Park, Y.H. Choi, A.R. Gwon, S. Camandola, A. Cheng, H. Cai, W. Song, W.R. Markesbery, and M.P. Mattson Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease Neurobiol. Aging 31 2010 917 925
28. P. Gamba, G. Leonarduzzi, E. Tamagno, M. Guglielmotto, G. Testa, B. Sottero, S. Gargiulo, F. Biasi, A. Mauro, J. Viña, and G. Poli Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime Aging Cell 10 2011 403 417
29. M.R. Yun, D.S. Im, S.J. Lee, H.M. Park, S.S. Bae, W.S. Lee, and C.D. Kim 4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase Free Radic. Biol. Med. 46 2009 692 698
30. M.E. Bamberger, M.E. Harris, D.R. McDonald, J. Husemann, and G.E. Landreth A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation J. Neurosci. 23 2003 2665 2674
31. C.R. Stewart, L.M. Stuart, K. Wilkinson, J.M. van Gils, J. Deng, A. Halle, K.J. Rayner, L. Boyer, R. Zhong, W.A. Frazier, A. Lacy-Hulbert, J. El Khoury, D.T. Golenbock, and K.J. Moore CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Nat. Immunol. 11 2010 155 161
32. L. Park, G. Wang, P. Zhou, J. Zhou, R. Pitstick, M.L. Previti, L. Younkin, S.G. Younkin, W.E. Van Nostrand, S. Cho, J. Anrather, G.A. Carlson, and C. Iadecola Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta Proc. Natl. Acad. Sci. USA 108 2011 5063 5068
33. M.V. Aksenova, M.Y. Aksenov, C.F. Mactutus, and R.M. Booze Cell culture models of oxidative stress and injury in the central nervous system Curr. Neurovasc. Res. 2 2005 73 89
34. L. Agholme, T. Lindström, K. Kågedal, J. Marcusson, and M. Hallbeck An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons J. Alzheimers Dis. 20 2010 1069 1082
35. Y. Chai, X. Jiang, Y. Ito, P. Bringas Jr, J. Han, D.H. Rowitch, P. Soriano, A.P. McMahon, and H.M. Sucov Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis Development 127 2000 1671 1679
36. M. Rothová, J. Feng, P.T. Sharpe, R. Peterková, and A.S. Tucker Contribution of mesoderm to the developing dental papilla Int. J. Dev. Biol. 55 2011 59 64
37. G.T. Huang, S. Gronthos, and S. Shi Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine J. Dent. Res. 88 2009 792 806
38. Sprio, A.E.; Di Scipio, F.; Raimondo, S.; Salamone, P.; Pagliari, F.; Pagliari, S., Folino, A.; Forte, G.; Geuna, S.; Di Nardo, P.; Berta, G.N. Self-renewal and multipotency coexist in a long-term cultured adult rat dental pulp stem cell line: an exception to the rule? Stem Cells Dev. In press; 2012.
39. S. Gronthos, M. Mankani, J. Brahim, P.G. Robey, and S. Shi Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo Proc. Natl. Acad. Sci. USA 97 2000 13625 13630
40. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method Methods 25 2001 402 408
41. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem 72 1976 248 254
42. D.J. Selkoe Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease Curr. Opin. Neurobiol. 4 1994 708 716
43. G. Poli, R.J. Schaur, W.G. Siems, and G. Leonarduzzi 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest Med. Res. Rev. 28 2008 569 631
44. D.A. Butterfield, T. Reed, M. Perluigi, C. De Marco, R. Coccia, and C. Cini Sultana, R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neurosci. Lett. 397 2006 170 173
45. K. Jomova, D. Vondrakova, M. Lawson, and M. Valko Metals, oxidative stress and neurodegenerative disorders Mol. Cell. Biochem. 345 2010 91 104
46. D.A. Butterfield, M.L. Bader Lange, and R. Sultana Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease Biochim Biophys. Acta 1801 2010 924 929
47. E.K. Long, and M.J. Picklo Sr. Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE Free Radic. Biol. Med. 49 2010 1 8
48. M.A. Bradley, S. Xiong-Fister, W.R. Markesbery, and M.A. Lovell Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression Neurobiol. Aging 33 2012 1034 1044
49. T.N. Dang, M. Arseneault, V. Murthy, and C. Ramassamy Potential role of acrolein in neurodegeneration and in Alzheimer's disease Curr. Mol. Pharmacol. 3 2010 66 78
50. M. Singh, T.N. Dang, M. Arseneault, and C. Ramassamy Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein J. Alzheimers Dis. 21 2010 741 756
51. J.N. Keller, and M.P. Mattson Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system Rev. Neurosci. 9 1998 105 116
52. G. Perry, R.J. Castellani, K. Hirai, and M.A. Smith Reactive oxygen species mediate cellular damage in alzheimer disease J. Alzheimers Dis. 1 1998 45 55
53. K. Uchida A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress Mol. Cells 25 2008 347 351
54. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radic. Biol. Med 32 2002 1050 1060
55. H.M. Abdul, R. Sultana, D.K. St Clair, W.R. Markesbery, and D.A. Butterfield Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age Free Radic. Biol. Med. 45 2008 1420 1425
56. M.E. Bamberger, M.E. Harris, D.R. McDonald, J. Husemann, and G.E. Landreth A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation J. Neurosci. 23 2003 2665 2674
57. C.R. Stewart, L.M. Stuart, K. Wilkinson, J.M. van Gils, J. Deng, A. Halle, K.J. Rayner, L. Boyer, R. Zhong, W.A. Frazier, A. Lacy-Hulbert, J. El Khoury, D.T. Golenbock, and K.J. Moore CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Nat. Immunol. 11 2010 155 161
58. S.C. Tang, J.D. Lathia, P.K. Selvaraj, D.G. Jo, M.R. Mughal, A. Cheng, D.A. Siler, W.R. Markesbery, T.V. Arumugam, and M.P. Mattson Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal Exp. Neurol. 213 2008 114 121
59. A. Mohamed, and E. Posse de Chaves Aβ internalization by neurons and glia Int. J. Alzheimers Dis. 2011 127984
60. Wirths, O.; Bayer, T.A. Intraneuronal Aβ accumulation and neurodegeneration: lessons from transgenic models. Life Sci. In press; 2012.
61. Y. Ohyagi, H. Asahara, D.H. Chui, Y. Tsuruta, N. Sakae, K. Miyoshi, T. Yamada, H. Kikuchi, T. Taniwaki, H. Murai, K. Ikezoe, H. Furuya, T. Kawarabayashi, M. Shoji, F. Checler, T. Iwaki, T. Makifuchi, K. Takeda, J. Kira, and T. Tabira Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease FASEB J. 19 2005 255 257
62. Y. Ohyagi, and T. Tabira Intracellular amyloid beta-protein and its associated molecules in the pathogenesis of Alzheimer's disease Mini Rev. Med. Chem 6 2006 1075 1080
63. Y. Ohyagi Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease Curr. Alzheimer Res 5 2008 555 561
64. J.A. Bailey, B. Maloney, Y.W. Ge, and D.K. Lahiri Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis Gene 488 2011 13 22
65. F. Magni, C. Galbusera, L. Tremolada, C. Ferrarese, and M.G. Kienle Characterisation of adducts of the lipid peroxidation product 4-hydroxy-2-nonenal and amyloid beta-peptides by liquid chromatography/ electrospray ionisation mass spectrometry Rapid. Commun. Mass Spectrom 16 2002 1485 1493